A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Laura R. Saunders; Alexander J. Bankovich; Wade C. Anderson; Monette A. Aujay; Sheila Bheddah; KristenAnn Black; Radhika Desai; Paul A. Escarpe; Johannes Hampl; Amy Laysang; David Liu; Javier Lopez-Molina; Milly Milton; Albert Park; Marybeth A. Pysz; Hui Shao; Brian Slingerland; Michael Torgov; Samuel A. Williams; Orit Foord; Philip Howard; Jacek Jassem; Andrzej Badzio; Piotr Czapiewski; David H. Harpole; Afshin Dowlati; Pierre P. Massion; William D. Travis; M. Catherine Pietanza; J. T. Poirier; Charles M. Rudin; Robert A. Stull; Scott J. Dylla

doi:10.1126/scitranslmed.aac9459

Research ArticleCancer

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Laura R. Saunders¹,
Alexander J. Bankovich¹,
Wade C. Anderson¹,
Monette A. Aujay¹,
Sheila Bheddah¹,
KristenAnn Black¹,
Radhika Desai¹,
Paul A. Escarpe¹,
Johannes Hampl¹,
Amy Laysang¹,
David Liu¹,
Javier Lopez-Molina¹,
Milly Milton¹,
Albert Park¹,
Marybeth A. Pysz¹,
Hui Shao¹,
Brian Slingerland¹,
Michael Torgov¹,*,
Samuel A. Williams¹,
Orit Foord¹,
Philip Howard²,
Jacek Jassem³,
Andrzej Badzio³,
Piotr Czapiewski³,
David H. Harpole⁴,
Afshin Dowlati⁵,
Pierre P. Massion⁶,
William D. Travis⁷,
M. Catherine Pietanza⁷,⁸,
J. T. Poirier⁷,⁸,
Charles M. Rudin⁷,
Robert A. Stull¹ and
Scott J. Dylla¹,†

¹Stemcentrx Inc., South San Francisco, CA 94080, USA.
²Spirogen (a member of the AstraZeneca Group), London W2 6BD, UK.
³Medical University of Gdańsk, Gdańsk 82-300, Poland.
⁴Duke University Medical Cancer, Durham, NC 27710, USA.
⁵Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH 44106, USA.
⁶Thoracic Program, Vanderbilt-Ingram Cancer Center, Tennessee Valley Healthcare Systems, Nashville Campus, Nashville, TN 37232, USA.
⁷Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
⁸Weill Cornell Medical College, New York, NY 10065, USA.

↵†Corresponding author. E-mail: scott.dylla{at}stemcentrx.com

↵* Present address: ImaginAb Inc., Inglewood, CA 90301, USA.

See allHide authors and affiliations

Science Translational Medicine 26 Aug 2015:
Vol. 7, Issue 302, pp. 302ra136
DOI: 10.1126/scitranslmed.aac9459

Laura R. Saunders

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander J. Bankovich

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wade C. Anderson

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Monette A. Aujay

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sheila Bheddah

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

KristenAnn Black

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Radhika Desai

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Paul A. Escarpe

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Hampl

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amy Laysang

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David Liu

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Javier Lopez-Molina

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Milly Milton

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Albert Park

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marybeth A. Pysz

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hui Shao

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brian Slingerland

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Torgov

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samuel A. Williams

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Orit Foord

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philip Howard

Spirogen (a member of the AstraZeneca Group), London W2 6BD, UK.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jacek Jassem

Medical University of Gdańsk, Gdańsk 82-300, Poland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andrzej Badzio

Medical University of Gdańsk, Gdańsk 82-300, Poland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Piotr Czapiewski

Medical University of Gdańsk, Gdańsk 82-300, Poland.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David H. Harpole

Duke University Medical Cancer, Durham, NC 27710, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Afshin Dowlati

Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH 44106, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pierre P. Massion

Thoracic Program, Vanderbilt-Ingram Cancer Center, Tennessee Valley Healthcare Systems, Nashville Campus, Nashville, TN 37232, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William D. Travis

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

M. Catherine Pietanza

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.Weill Cornell Medical College, New York, NY 10065, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J. T. Poirier

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.Weill Cornell Medical College, New York, NY 10065, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Charles M. Rudin

Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert A. Stull

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Scott J. Dylla

Stemcentrx Inc., South San Francisco, CA 94080, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: scott.dylla@stemcentrx.com

Article
Figures & Data
Info & Metrics
eLetters
PDF

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Submit a Response to This Article

Compose eLetter

Title

Contents

More information about text formats

Plain text

Plain text
No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First name and middle name First or given name, e.g. 'Peter'. Last Name Your last, or family, name, e.g. 'MacMoody'. Email Your email address, e.g. higgs-boson@gmail.com Role / Occupation Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests?

Yes

Please describe the competing interests

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

What code is in the image? Enter the characters shown in the image.

Vertical Tabs

No eLetters have been published for this article.

View Full Text

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Plain text

Vertical Tabs

Science Translational Medicine

Article Tools